Anti‐atherogenic and anti‐inflammatory properties of glucagon‐like peptide‐1, glucose‐dependent insulinotropic polypepide, and dipeptidyl peptidase‐4 inhibitors in experimental animals

We reported that native incretins, liraglutide and dipeptidyl peptidase‐4 inhibitors (DPP‐4i) all confer an anti‐atherosclerotic effect in apolipoprotein E‐null (Apoe (−/−)) mice. We confirmed the anti‐atherogenic property of incretin‐related agents in the mouse wire injury model, in which the neoin...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Diabetes Investig
Autori principali: Hirano, Tsutomu, Mori, Yusaku
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Proceedings of INCRETIN 2015, A Symposium Celebrating the 45th Anniversary of the Discovery of GIP, 29–31 July 2015, Vancouver, Canada. This publication has been supported by: The Local Organizing Committee of INCRETIN 2015
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4854510/
https://ncbi.nlm.nih.gov/pubmed/27186361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12446
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi